Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients
Author(s):
Smolen, J.S.; Vollenhoven, R. van; Kavanaugh, A.; Strand, V.; Vencovsky, J.; Schiff, M.; Landewe, R.; Haraoui, B.; Arendt, C.; Mountian, I.; Carter, D.; Heijde, D. van der
